NSTG News and Press, NanoString Technologies Inc. From 11/17/23

2023-11-17 05:55:00 ET Summary Biotech sector faces challenges including higher interest rates, inflation, regulatory pressures, and a post-COVID slump. Short interest remains high for some pharmaceutical companies, indicating bearish sentiment. Exchange-traded funds in the bi...

Twenty-two posters and two symposia to be offered at Neuroscience 2023 NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today it will present at the Society for Neuroscience (SfN) annual meeting a large body of new br...

2023-11-06 22:27:10 ET NanoString Technologies, Inc. (NSTG) Q3 2023 Earnings Conference Call November 06, 2023, 16:30 PM ET Company Participants Doug Farrell - IR Brad Gray - President and CEO Tom Bailey - CFO Conference Call Participants Marta Nazaro...

2023-11-06 16:05:01 ET More on NanoString NanoString expects Q3 results to top forecasts; reorganizes operations Seeking Alpha’s Quant Rating on NanoString Historical earnings data for NanoString Financial information for NanoString For further...

Completed Exchange Transaction with Convertible Note Holders Representing 94% of Outstanding Principal – Record Q3 Revenue of $48.1 Million, 63% Year on Year Growth and Above Upper End of Q3 Guidance Range – NanoString Technologies, Inc. (NASDAQ:NSTG), a leading pr...

CGG ADR (CGGYY) is expected to report for quarter end 2023-09-30 ATI Physical Therapy Inc. Class A (ATIP) is expected to report $-4.08 for Q3 2023 Riot Platforms Inc. (RIOT) is expected to report $-0.29 for Q3 2023 Bain Capital Specialty Finance Inc. (BCSF) is expected to report $0.57...

NanoString Technologies Inc. (NSTG) is expected to report $-0.53 for Q3 2023

2023-11-05 17:35:55 ET Major earnings expected after the bell on Monday include: Realty Income Corporation ( O ) Vertex Pharmaceuticals Incorporated ( VRTX ) NXP Semiconductors N.V. ( NXPI ) Alteryx ( AYX ) Tanger Factory Outlet Centers ( SKT ) ...

Leading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoS...

2023-10-29 17:28:12 ET More on Guardant Health, Natera, etc. Natera: Cash Burn Remains A Concern Guardant Health: Peeling Back Economic Layers, Compressed Market Values Appear Justified Pacific Biosciences: Looks Appealing In The Fast-Growing Long-Read Sequencing Mar...